MORGAN STANLEY - ACASTI PHARMA INC ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q2 2023$5,931
+14.2%
11,2950.0%0.00%
Q1 2023$5,195
-8.2%
11,2950.0%0.00%
Q4 2022$5,659
-5.7%
11,2950.0%0.00%
Q3 2022$6,000
-62.5%
11,295
-39.5%
0.00%
Q2 2022$16,000
-75.8%
18,664
-65.7%
0.00%
Q1 2022$66,000
+57.1%
54,464
+63.4%
0.00%
Q4 2021$42,000
+44.8%
33,331
+126.0%
0.00%
Q3 2021$29,00014,7490.00%
Other shareholders
ACASTI PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 27,100$54,0000.01%
TWO SIGMA SECURITIES, LLC 13,370$27,0000.00%
BREWIN DOLPHIN LTD 3$60.00%
Renaissance Technologies 43,408$87,0000.00%
ROYAL BANK OF CANADA 955$2,0000.00%
JANE STREET GROUP, LLC 18,919$38,0000.00%
UBS Group AG 4,500$9,0000.00%
Sargent Bickham Lagudis LLC 5$00.00%
BANK OF AMERICA CORP /DE/ 625$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACASTI PHARMA INC shareholders